Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine for ventricular rate control in permanent or persistent atrial fibrillation
IRCT20240207060933N1Phase 2Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ivabradine in Atrial fibrillation (AFib), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Heart beat and Ventricular response. Started Mar 2024; status: completed.
02
Drugs
ivabradine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on IRCT20240207060933N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240207060933N1.